BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

Rockefeller Capital Management L.P.'s Holding History (CIK: 0001739439)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 26,797 Value ($000) $209 Avg Close $7.23 Range $6.00 - $8.17
Q3 2025
Shares 5,325 Value ($000) $40 Avg Close $8.33 Range $7.42 - $9.23
Q2 2025
Shares 25,542 Value ($000) $229 Avg Close $9.31 Range $6.02 - $11.31
Q3 2024
Shares 26,400 Value ($000) $201 Avg Close $7.60 Range $6.17 - $8.88
Q4 2022
Shares 3,800 Value ($000) $0 Avg Close $12.47 Range $10.36 - $14.50
Q3 2022
Shares 3,800 Value ($000) $47 Avg Close $12.87 Range $10.33 - $15.43
Q2 2022
Shares 3,800 Value ($000) $40 Avg Close $10.32 Range $7.61 - $18.00
Q1 2022
Shares 3,828 Value ($000) $62 Avg Close $16.04 Range $11.56 - $19.99
Q4 2021
Shares 3,800 Value ($000) $52 Avg Close $13.23 Range $10.72 - $15.77
Q3 2021
Shares 3,800 Value ($000) $54 Avg Close $15.77 Range $14.00 - $18.48
Q2 2021
Shares 3,800 Value ($000) $60 Avg Close $13.59 Range $9.23 - $17.74
Q1 2021
Shares 3,800 Value ($000) $38 Avg Close $10.31 Range $7.27 - $14.24
Q4 2020
Shares 3,300 Value ($000) $24 Avg Close $5.16 Range $3.36 - $8.99
Q3 2020
Shares 3,300 Value ($000) $11 Avg Close $4.29 Range $3.30 - $6.03
Q2 2020
Shares 3,300 Value ($000) $16 Avg Close $3.99 Range $1.80 - $6.29
Q1 2020
Shares 3,300 Value ($000) $7 Avg Close $2.75 Range $1.58 - $4.35